ENTRY       D12374                      Drug
NAME        Sibeprenlimab (INN)
FORMULA     C6488H10002N1744O2013S52
EXACT_MASS  146217.9378
MOL_WEIGHT  146308.6945
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT DYTIHWVRQA TGQGLEWMGW IYPLRGSINY
            AQKFQGRVTM TADKSISTVY MELSSLRSED TAVYFCARHG AYYSNAFDYW GQGTLVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP APPVAGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTFR
            VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            EIVMTQSPAT LSVSPGERAT LSCRASESVD NDGIRFLHWY QQKPGQAPRL LIYRASTRAT
            GIPARFSGSG SRTEFTLTIS SLQSEDFAVY YCQQSNKDPY TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H134-L218, H147-H203, H222-H'222, H223-H'223, H226-H'226, H229-H'229, H260-H320, H366-H424, H'22-H'96, H'134-L'218, H'147-H'203, H'260-H'320, H'366-H'424, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Autoimmune disease treatment
  TYPE      Monoclonal antibody
COMMENT     Treatment of IgA nephropathy (IgAN)
TARGET      TNFSF13 (APRIL, CD256) [HSA:8741] [KO:K05475]
  PATHWAY   hsa04060(8741)  Cytokine-cytokine receptor interaction
            hsa04672(8741)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF13 (APRIL, CD256)
                 D12374  Sibeprenlimab (INN)
DBLINKS     CAS: 2382896-07-1
///
